A study of asthmatic patients divided into two groups: controlled asthma and exacerbated asthma, showed a positive correlation between elevated levels of MCP.4 and exacerbation of the disease, revealing the role of this chemokine in the systemic inflammatory process [24]. This evidence concerns the gene CCL13 and asthma.